AdProTech Limited
GB· latest recorded location
AdProTech Limited is named on 10 US grants and 7 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 10
- Published applications
- 7
- Inventors
- 15
- Granted in 2026 so far
- 0
- Most recent grant
- 4 Jun 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 4 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
By publication year.
Technology areas
Share of 17 documents
Recent patents
- Modified therapeutic agents4 Jun 2013US 8,455,447 B2
- Method of preparing an organ by perfusion15 Feb 2011US 7,888,318 B1
- Conjugates of soluble peptidic compounds with membrane-binding agents2 Feb 2010US 7,655,617 B2
- Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements18 Jul 2006US 7,078,380 B2
- Complement receptor type 1 (CR1)-like sequences21 Dec 2004US 6,833,437 B2
- Modified therapeutic agents14 Apr 2011US 2011/0086808 A1
- Conjugates of soluble peptidic compounds with membrane-binding agents11 Nov 2010US 2010/0286367 A1
- Compounds targeted to cellular locations8 Feb 2007US 2007/0031444 A1
- Conjugates of soluble peptidic compounds with membrane-binding agents30 Dec 2004US 2004/0266684 A1
- Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements3 Jun 2004US 2004/0106544 A1
Most cited
By later US patents
- Conjugates of soluble peptidic compounds with membrane-binding agents16US 6,713,606 B12004
- Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane associating elements6US 7,078,380 B22006
- Soluble CR1 derivatives5US 5,833,989 A1998
- Soluble CR1 derivatives1US 5,859,223 A1999
- Non-identical genes and their application in improved molecular adjuvants1US 6,770,631 B12004